ORIGINAL ARTICLEOptimal timing of hepatitis C treatment among HIV/HCV coinfected ESRD patients: Pre- vs posttransplant
Under a Creative Commons license
open archive
KEYWORDS
health services and outcomes research
infection and infectious agents - viral: hepatitis C
infection and infectious agents - viral: human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS)
kidney transplantation/nephrology
Abbreviations
AWP
average wholesale pricing
CKD
chronic kidney disease
DAA
direct-acting antiviral
ESRD
end-stage renal disease
HCV+
hepatitis C virus infection
HCV−
hepatitis C negative
HIV
human immunodeficiency virus
ICER
incremental cost-effectiveness ratio
IQR
interquartile range
KDPI
kidney donor profile index
LM
life months
METAVIR
meta-analysis of histologic data in viral hepatitis
NIH
National Institutes of Health
PSR
program-specific report
OPO
organ procurement organization
QALM
quality adjusted life months
QALY
quality-adjusted life years
QoL
quality of life
SD
standard deviation
SRTR
Scientific Registry of Transplant Recipients
SVR
sustained viral response
UNOS
United Network for Organ Sharing
USRDS
United States Renal Data System
Cited by (0)
Copyright © 2019 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.